News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
215 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17656)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (201)
2 (268)
3 (272)
4 (305)
5 (108)
6 (6)
7 (10)
8 (235)
9 (334)
10 (239)
11 (333)
12 (116)
13 (2)
14 (3)
15 (255)
16 (204)
17 (173)
18 (167)
19 (88)
20 (9)
21 (8)
22 (183)
23 (215)
24 (191)
25 (218)
26 (104)
28 (2)
29 (12)
30 (225)
31 (296)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
28
29
30
31
Propanc Biopharma’s Intellectual Property Portfolio Achieves Significant Milestones in North America
Propanc Biopharma, Inc., a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced that the Company’s intellectual property portfolio achieved significant milestones in North America.
May 23, 2023
·
5 min read
Business
Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health’s ModeX Therapeutics
Nona Biosciences today announced it has entered into an agreement with ModeX Therapeutics, an OPKO Health company, for the use of Nona’s platforms to support ModeX’s development of multispecific antibody therapeutics.
May 23, 2023
·
3 min read
OMRON Healthcare Celebrates 50 Years of Blood Pressure Monitor History
OMRON Healthcare Co., Ltd. based in Muko City, Kyoto Prefecture, Japan, is proud to announce the celebration of its 50th anniversary in blood pressure monitor production this year.
May 23, 2023
·
4 min read
Drug Development
MindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive Disorder
MindBio Therapeutics Corp. is pleased to announce that ethics approval has been received for a world’s first Phase 2a take home LSD-Microdosing clinical trial in patients with Major Depressive Disorder.
May 23, 2023
·
6 min read
Business
BioInvent Strengthens Management with Appointment of Ingunn Munch Lindvig as Senior Vice President Regulatory Affairs
BioInvent International AB announces the appointment of Ingunn Munch Lindvig as Senior Vice President Regulatory Affairs.
May 23, 2023
·
2 min read
Biotech Bay
BioCardia Announces Timing of the Next Data Safety Monitoring Board Meeting for the CardiAMP Cell Therapy in Heart Failure Pivotal Study
BioCardia®, Inc. today announced that the next Data Safety Monitoring Board (DSMB) meeting for the CardiAMP Cell Therapy Trial for Heart Failure is scheduled to take place on July 12th.
May 23, 2023
·
3 min read
BioCapital
GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations
GeneDx today announced that it will participate in multiple presentations at the World Orphan Drug Congress in Washington, D.C., May 23-25, 2023.
May 23, 2023
·
3 min read
Drug Development
Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study
Minghui Pharmaceutical, Inc., today announced that the phase 1a trial of MHB018A has commenced with the dosing of its first subject.
May 23, 2023
·
4 min read
Biotech Beach
Strong Analytical Validation Data Further Supports Use of DCISionRT® to Guide Shared Decision-Making for DCIS Therapeutic Management
Prelude Corporation announced that a paper titled “Analytical Validation of the 7-gene Biosignature for Prediction of Recurrence Risk and Radiation Therapy Benefits for Breast Ductal Carcinoma in Situ” was published in Frontiers in Oncology.
May 23, 2023
·
5 min read
Business
KALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME FOR PRODUCTION OF AN ADVANCED BEVERAGE INGREDIENT
Willow Biosciences Inc. and Kalsec® Inc. announce entry into a follow-on Master Services Agreement (the “MSA”) to develop an enzyme used in biocatalytic production of a new, advanced ingredient used in natural beverage applications.
May 23, 2023
·
6 min read
Previous
9 of 22
Next